Phase Forward
Provider of integrated data collection and data management solutions for clinical trials and drug safety.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor investor investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
$685m Valuation: $685m | Acquisition | ||
| Total Funding | 000k | ||
Thomas Weisel Partners(exited)
Sprout Group(exited)
Bioventures Investors(exited)
SV Health Investors(exited)
HLM Venture Partners(exited)
Pacific Venture Group(exited)
Atlas Venture(exited)
NEA(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Investments by Phase Forward
Edit
ACQUISITION by Phase Forward Apr 2009